Updated figures 2018-2021: Revenue/EBITDA/Forward Earnings As i was asked after posting Chartguys outlook for the next week about future revenues and longterm view on Wallstreet Online.
Here is my summary and extrapolation of all new Purchases from Aphria with participation in DOJA / Broken Coast participation in DOJA / Broken Coast (without some other Partnerstakes like Tetra Biopharma, Scythian Bioscience, CannaRoyalty a.s,o).
Let's see if we actually make this development this year in 2018, then I see rather lower hurdles, since then all licenses with expansion and internationality and an almost mainstream (broad mass) cannabis globalization should be reached - at least in North America so Canada & USA and certainly also Europe!
Sure, the Aphria management with their Partners will raise the bar with every news, but also the real sales and estimated profit margins with EBITDA have to be achieved - at least as a trend! 